HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

CDC’s License Revenue to Drop

Share
By: Zacks Equity Research
October 16, 2009 | Comment(s): 0
Recommended this article (6)

CDC Software Corp (CDCS), a wholly owned subsidiary of CDC Corp. (CHINA) said that it expects a decline in its license revenue. The company expects software license revenue to fall in the range of $7.4 – $7.6 million in the third quarter of 2009. The mid-point of the range is a decline of 37% from the year-ago period and 4% from the previous quarter. 

We believe this fall is mainly due to the declining business activity the company felt during this economic downturn, which had a negative impact on the overall enterprise software industry. 

Despite the sequential and year-over-year decline in license revenue, the overall revenue estimates are in line with the First Call Consensus estimates of $7.4 million. The company also said that the license revenue from new logo business increased to 24% in the forecasted quarter, up from 12% reported in the previous quarter. 

CDC Software’s top 10 deals in the quarter included six deals in the food and beverage and financial services/insurance markets. 

CDC Software is a leading provider of enterprise software applications and services. The company generates software revenues from the sale of software licenses and the maintenance and services for such software licenses. CDC has historically achieved 15.0% to 20.0% organic license revenue growth, which may be among the strongest in the industry. 

With a strong organic growth in its software business, we believe CDC is poised to grow. With a continuous focus on vertical industries, cost reduction initiatives in its software segment, new launches and upgrades in its product line as well as integration efforts, CDC should develop a significant competitive advantage in 2009 and beyond. 

Also, an increase in license bookings and a strong pipeline of sales opportunities at CDC Software should drive growth. Moreover, the company remained upbeat on its fourth quarter of 2009 outlook but did not provide any specific guidance.

Read the full analyst report on CDCS

Read the full analyst report on CHINA

 

Please login to Zacks.com or register to post a comment.


Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 00:13 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center